SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-014592
Filing Date
2021-04-02
Accepted
2021-04-02 16:30:29
Documents
2
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4141
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4590
  Complete submission text file 0000899243-21-014592.txt   10077
Mailing Address C/O CIVITAS THERAPEUTICS, INC. 190 EVERETT AVENUE CHELSEA MA 02150
Business Address
Stuart Bryan (Reporting) CIK: 0001619846 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38978 | Film No.: 21802332

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations